AxoGen reports Q1 adjusted EPS 7c, consensus 7c

Reports Q1 revenue $61.46M, consensus $57.77M. “We are pleased with our first-quarter revenue performance and the progress we’re making across each of Axogen’s (AXGN) strategic plan priorities,” said Michael Dale, president and CEO of Axogen, Inc. “We delivered strong growth across all of our target markets, reinforcing the relevance of our market development strategies and the strength of our commercial execution. We remain well positioned to achieve our financial guidance and continue advancing our strategic objectives for 2026.”